5 results about "Arterial aneurysms" patented technology

This invention provides a balloon catheter comprising a catheter, a balloon, and a limiting element. The balloon is positioned distal to or near the distal end of the catheter. The limiting element is located on the outer side of the balloon, and at least a portion of the limiting element is capable of radial movement or radial deformation to drive the balloon to move radially inward. The balloon catheter provided by this invention allows physicians to adjust the limiting element to contact the balloon and deform it, ensuring that a portion of the balloon remains firmly attached to the blood vessel. This reduces the risk of balloon displacement, prevents the balloon from losing its function of dilating blood vessels or blocking aneurysms due to displacement, and improves the stability and reliability of balloon implantation. Simultaneously, it allows another portion of the balloon to no longer be tightly attached to the blood vessel wall, creating a gap to form a fluid channel, allowing a small amount of blood to flow between the two ends of the balloon, ensuring blood supply to distal organs, reducing surgical complications, reducing pressure on patients and physicians, and increasing the success rate of surgery.

Devices and methods for treatment of a patient's vasculature including occluding aneurysms and blood vessels are described. The device includes a self-expanding resilient permeable shell having a radially constrained state and an expanded state with an axially shortened configuration. The permeable shell may be a single layer of braided elongate filaments having first and second ends that are secured at the proximal end of the permeable shell. The devices may also include permeable shells made of woven braided mesh having a variable mesh density, i.e., the average size of pores in one region are a different than the average size of pores in another region. Devices and methods of using the device to treat a cerebral aneurysm are also described.

The application relates to the technical field of medical image processing, and discloses an intracranial aneurysm recognition method and system based on a brain CT. The method obtains a brain CT image sequence, adopts an anisotropic diffusion filtering algorithm for pretreatment to suppress noise and retain blood vessel edge details. Subsequently, a region growing algorithm is used to segment an intracranial blood vessel region, and a skeletonization algorithm is used to extract a blood vessel center line to calculate curvature and diameter changes. Finally, based on curvature anomaly and diameter ratio analysis, combined with a multi-scale sliding window and a blood vessel topological structure verification, automatic recognition of intracranial aneurysms is realized, and the accuracy and reliability of diagnosis are improved.

This invention discloses a biomarker combination and its screening method, relating to the field of biotechnology. The biomarker combination includes lactate, glutamine, arginine, and 3-methylpentenoic acid, applied to assess the rupture risk of cerebral aneurysms. The screening method for the biomarker combination involves: collecting metabolic fingerprints from serum of patients with cerebral aneurysms and healthy controls using nanoparticle-enhanced laser desorption / ionization mass spectrometry; and performing machine learning to screen the biomarker combination. This invention utilizes nanoparticle-enhanced laser desorption / ionization mass spectrometry to screen lactate, glutamine, arginine, and 3-methylpentenoic acid as metabolic biomarkers, and uses these biomarkers to assess the rupture risk of cerebral aneurysms. Significant differences were observed between the low-risk and high-risk groups (P < 0.05).